Renal Fractional Flow Reserve in Renal Artery Stenting

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-06-30

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine potential utility of renal fractional flow reserve in prognosis predicting after renal stent implantation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

NCT02053038

Coronary Artery Disease

UNKNOWN NA

Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis

NCT00150943

Renal Artery Obstruction Kidney Failure

COMPLETED PHASE3

Fractional Flow Reserve to Determine Atherosclerosis Renovascular Hypertension Stenting

NCT05732077

Renal Artery Stenosis Atherosclerotic Secondary Hypertension Renal Arterial

RECRUITING NA

Outcomes With Fractional Flow Reserve in Chronic Coronary Syndrome

NCT05592535

Chronic Coronary Syndrome

COMPLETED

Angiography-derived FFR GPS in Predicting Post-PCI Physiological and Clinical Outcomes

NCT05496023

Coronary Artery Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Artery Stenosis Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hypertensive patients

Hypertensive patients with at least moderate renal artery stenosis

Group Type EXPERIMENTAL

Renal artery stenting

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Renal artery stenting

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least moderate (60% or more) renal artery stenosis with atheromatic appearance in angiography
* Hypertension defined according to WHO criteria
* Age 18-75 years
* Signed informed consent obtained

Exclusion Criteria

* Bilateral renal artery stenosis or significant renal artery stenosis in solitary kidney
* Contraindications to percutaneous renal angioplasty with stenting
* Atrophy of the kidney supplied with stenosed artery
* Other well known secondary reason for hypertension
* Chronic heart failure NYHA II-IV
* Significant valvular heart disease qualified for surgery
* Persistent atrial fibrillation
* Renal failure with GFR below 30ml/min

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No